126 related articles for article (PubMed ID: 8244317)
1. p53 accumulation in ovarian carcinomas and its prognostic implications.
Bosari S; Viale G; Radaelli U; Bossi P; Bonoldi E; Coggi G
Hum Pathol; 1993 Nov; 24(11):1175-9. PubMed ID: 8244317
[TBL] [Abstract][Full Text] [Related]
2. Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.
van der Zee AG; Hollema H; Suurmeijer AJ; Krans M; Sluiter WJ; Willemse PH; Aalders JG; de Vries EG
J Clin Oncol; 1995 Jan; 13(1):70-8. PubMed ID: 7799045
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma.
Levesque MA; Katsaros D; Yu H; Zola P; Sismondi P; Giardina G; Diamandis EP
Cancer; 1995 Mar; 75(6):1327-38. PubMed ID: 7882283
[TBL] [Abstract][Full Text] [Related]
4. Quantification of p53 in epithelial ovarian cancer.
Geisler JP; Geisler HE; Wiemann MC; Givens SS; Zhou Z; Miller GA
Gynecol Oncol; 1997 Sep; 66(3):435-8. PubMed ID: 9299258
[TBL] [Abstract][Full Text] [Related]
5. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE
Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189
[TBL] [Abstract][Full Text] [Related]
6. bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.
Diebold J; Baretton G; Felchner M; Meier W; Dopfer K; Schmidt M; Löhrs U
Am J Clin Pathol; 1996 Mar; 105(3):341-9. PubMed ID: 8602616
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of p53 accumulation in epithelial ovarian carcinomas.
Berker B; Dunder I; Ensari A; Cengiz SD
Arch Gynecol Obstet; 2002 Aug; 266(4):205-9. PubMed ID: 12192480
[TBL] [Abstract][Full Text] [Related]
8. Immunostaining of p53 protein in ovarian carcinoma: correlation with histopathological data and clinical outcome.
Reles A; Schmider A; Press MF; Schönborn I; Friedmann W; Huber-Schumacher S; Strohmeyer T; Lichtenegger W
J Cancer Res Clin Oncol; 1996; 122(8):489-94. PubMed ID: 8698749
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cytosolic p53 protein levels in the female genital tract and breast, and their tumors.
Westhof G; Bader W; Greiner-Mai E; Hatzmann W
Tumour Biol; 2000; 21(3):123-34. PubMed ID: 10754462
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary.
Werness BA; Freedman AN; Piver MS; Romero-Gutierrez M; Petrow E
Gynecol Oncol; 1999 Dec; 75(3):413-8. PubMed ID: 10600299
[TBL] [Abstract][Full Text] [Related]
12. p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma.
Klemi PJ; Pylkkänen L; Kiilholma P; Kurvinen K; Joensuu H
Cancer; 1995 Oct; 76(7):1201-8. PubMed ID: 8630898
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of p53 immunostaining in epithelial ovarian cancer.
Hartmann LC; Podratz KC; Keeney GL; Kamel NA; Edmonson JH; Grill JP; Su JQ; Katzmann JA; Roche PC
J Clin Oncol; 1994 Jan; 12(1):64-9. PubMed ID: 8270986
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer.
Skírnisdóttir I; Seidal T
Int J Gynecol Cancer; 2011 Aug; 21(6):1024-31. PubMed ID: 21792012
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of p53 expression quantitated by computerized image analysis in epithelial ovarian cancer.
Anttila MA; Ji H; Juhola MT; Saarikoski SV; Syrjänen KJ
Int J Gynecol Pathol; 1999 Jan; 18(1):42-51. PubMed ID: 9891240
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow.
Schindlbeck C; Hantschmann P; Zerzer M; Jahns B; Rjosk D; Janni W; Rack B; Sommer H; Friese K
Int J Gynecol Cancer; 2007; 17(5):1047-55. PubMed ID: 17433065
[TBL] [Abstract][Full Text] [Related]
17. Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up.
Bosari S; Lee AK; Viale G; Heatley GJ; Coggi G
Virchows Arch A Pathol Anat Histopathol; 1992; 421(4):291-5. PubMed ID: 1413493
[TBL] [Abstract][Full Text] [Related]
18. Micrometastatic p53-positive cells in the lymph nodes of early stage epithelial ovarian cancer: prognostic significance.
Suzuki M; Ohwada M; Saga Y; Kohno T; Takei Y; Sato I
Oncology; 2001; 60(2):170-5. PubMed ID: 11244333
[TBL] [Abstract][Full Text] [Related]
19. p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity.
Röhlke P; Milde-Langosch K; Weyland C; Pichlmeier U; Jonat W; Löning T
J Cancer Res Clin Oncol; 1997; 123(9):496-501. PubMed ID: 9341899
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
